Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
SEPN
Stock Latest News
The Fly
Septerna price target raised to $35 from $34 at Truist
2d ago
SEPN
Premium
The Fly
Septerna files automatic mixed securities shelf
3d ago
SEPN
Premium
Ratings
Septerna: Novo-Backed GPCR Platform and Best-in-Class Potential for Oral MRGPRX2 Inhibitor SEP-631 Support Buy Rating
3d ago
SEPN
Premium
The Fly
Septerna reports Q4 EPS (24c), consensus (22c)
4d ago
SEPN
Premium
Ratings
Septerna (SEPN): Early Proof-of-Concept for SEP-631 in Mast Cell–Driven Disease Supports Long-Term Growth Potential
10d ago
SEPN
Premium
The Fly
Septerna price target raised to $40 from $35 at H.C. Wainwright
11d ago
SEPN
Premium
Company Announcements
Septerna Advances SEP-631 After Positive Phase 1 Results
11d ago
8K
SEPN
Premium
The Fly
Septerna announces results from Phase 1 trial of SEP-631
12d ago
SEPN
Premium
Ratings
Septerna: Advancing GPCR Pipeline and De-Risked Valuation Support Upgraded Buy Rating and $35 Target
2M ago
SEPN
Premium
The Fly
Septerna price target raised to $35 from $30 at H.C. Wainwright
2M ago
SEPN
Premium
Company Announcements
Septerna to Present GPCR Pipeline Updates at JPM Conference
2M ago
8K
SEPN
Premium
Company Announcements
Septerna Appoints Mark Wilson as Chief Legal Officer
2M ago
8K
SEPN
Premium
The Fly
Septerna appoints Mark Wilson as chief legal officer
2M ago
NKTR
SEPN
Premium
The Fly
Coty downgraded, Spruce Biosciences initiated: Wall Street’s top analyst calls
3M ago
BC
AME
Premium
The Fly
Septerna initiated with a Buy at JonesResearch
3M ago
SEPN
Premium
The Fly
Septerna initiated with a Strong Buy at Raymond James
3M ago
SEPN
Premium
The Fly
Septerna initiated with a Buy at Truist
3M ago
SEPN
Premium
The Fly
Septerna price target raised to $34 from $28 at JPMorgan
4M ago
SEPN
Premium
Pre-Earnings
SEPN Upcoming Earnings Report: What to Expect?
4M ago
SEPN
Premium
The Fly
Wells upgrades Septerna to Overweight on 2026 share catalysts
4M ago
SEPN
Premium
The Fly
Septerna upgraded to Overweight from Equal Weight at Wells Fargo
4M ago
SEPN
Premium
The Fly
Septerna price target raised to $30 from $26 at H.C. Wainwright
4M ago
SEPN
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.